Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Share Price
Stocks
600196
CNE000000X38
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Shanghai S.E.
23/10/2026
|
5-day change | 1st Jan Change | ||
| 23.18 CNY | +2.20% |
|
-0.04% | -12.50% |
| 10-22 | AriBio Secures KRW42.5 Billion Investment From Fosun Pharma | MT |
| 10-01 | Fosun Pharma Discloses 434 Million-Yuan Capital Reduction of Nanjing Fund | MT |
| Market Cap | 56.23B 8.44B 7.55B 6.97B 6.32B 11.8B 801B 12B 83.98B 33.22B 420B 31.68B 31.01B 1,324B | P/E 2026 * |
16x | P/E 2027 * | 14x |
|---|---|---|---|---|---|
| Enterprise Value | 69.1B 10.37B 9.28B 8.57B 7.77B 14.5B 985B 14.75B 103B 40.82B 516B 38.92B 38.1B 1,627B | EV / Sales 2026 * |
1.62x | EV / Sales 2027 * | 1.6x |
| Free-Float |
62.66% | Yield 2026 * |
1.94% | Yield 2027 * | 2.21% |
| 1 day | +2.20% | ||
| 1 week | -0.04% | ||
| Current month | -3.50% | ||
| 1 month | +0.22% | ||
| 3 months | -3.30% | ||
| 6 months | -9.42% | ||
| Current year | -12.50% |
| 1 week | 22.5 |  | 23.35 |
| 1 month | 22.5 | | 24.24 |
| Current year | 20.85 | | 28.71 |
| 1 year | 20.85 | | 29.68 |
| 3 years | 20.38 | | 33.1 |
| 5 years | 20.38 | | 58.95 |
| 10 years | 20.38 | | 91.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Liu
CEO | Chief Executive Officer | 50 | 23/06/2025 |
Zhi Huang
DFI | Director of Finance/CFO | - | 01/04/2026 |
Jing Li
PSD | President | 53 | 31/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Yu Chen
CHM | Chairman | 54 | 31/03/1994 |
Yi Liu
BRD | Director/Board Member | 50 | 01/12/2025 |
Dong Hui Pan
BRD | Director/Board Member | 56 | 29/06/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/05/25 | Sell | Chief Executive Officer | 87,448 | 0.0041% | ||
| 30/05/25 | Sell | Executive/Senior Manager | 31,790 | 0.0015% | ||
| 30/05/25 | Sell | Chairman | 63,614 | 0.0030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.20% | -0.04% | -19.63% | -14.62% | 8.25B | |
| -2.54% | +1.75% | +56.75% | +117.82% | 1,165B | |
| -1.42% | +4.16% | +36.73% | +72.42% | 645B | |
| +0.16% | +0.79% | +24.91% | +95.34% | 504B | |
| -0.31% | +2.95% | +39.36% | +63.56% | 380B | |
| -1.34% | +0.06% | +65.81% | +41.49% | 363B | |
| -0.68% | +1.67% | +22.07% | +50.94% | 297B | |
| -1.20% | +0.99% | +2.26% | +22.95% | 269B | |
| -1.79% | +1.20% | +48.41% | +57.55% | 237B | |
| -0.73% | -0.85% | +28.47% | +100.57% | 195B | |
| Average | -0.58% | +2.40% | +30.51% | +60.80% | 406.37B | |
| Weighted average by Cap. | -0.73% | +3.16% | +40.66% | +80.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 42.53B 6.38B 5.71B 5.27B 4.78B 8.92B 606B 9.08B 63.51B 25.12B 318B 23.96B 23.45B 1,001B | 43.6B 6.55B 5.85B 5.41B 4.9B 9.15B 621B 9.31B 65.12B 25.76B 326B 24.56B 24.04B 1,027B |
| Net income | 3.85B 579M 518M 478M 434M 809M 54.94B 823M 5.76B 2.28B 28.81B 2.17B 2.13B 90.75B | 4.3B 646M 577M 533M 484M 902M 61.29B 918M 6.42B 2.54B 32.14B 2.42B 2.37B 101B |
| Net Debt | 12.86B 1.93B 1.73B 1.6B 1.45B 2.7B 183B 2.75B 19.21B 7.6B 96.15B 7.25B 7.09B 303B | 14.06B 2.11B 1.89B 1.74B 1.58B 2.95B 200B 3B 21B 8.31B 105B 7.92B 7.76B 331B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | CN¥23.18 | +2.20% | 17,028,603 |
| 22/10/26 | CN¥22.68 | -1.61% | 12,490,183 |
| 21/10/26 | CN¥23.05 | -0.39% | 10,606,601 |
| 20/10/26 | CN¥23.14 | +0.92% | 11,948,060 |
| 19/10/26 | CN¥22.93 | -0.22% | 11,231,511 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600196 Stock
Select your edition
All financial news and data tailored to specific country editions
